Authors



Hiroshi Sat

Latest:

Prognosis of "masked" hypertension vs. "white-coat" hypertension

We compared the prognosis of patients with "white-coat" hypertension (WCHT) with that of patients with "masked" hypertension (MHT). The 10-year composite risk of stroke morbidity and cardiovascular mortality for patients with WCHT was similar to the risk for patients with sustained normal blood pressure, whereas the risk was markedly increased for patients with MHT and sustained hypertension. This indicates that conventional blood pressure measurements may fail to distinguish some patients at high or low risk.


Silas Inman
Silas Inman

Latest:

ChatGPT Effectively Modifies Medical Notes to Patient-Friendly Formats

Large language model AI tools like ChatGPT quickly, easily, and effectively modified dense medical information into grade 6 to 8 reading levels.


Sidney S. C. Wu, MD, FAAP

Latest:

Leprosy: Forgotten in America?

Leprosy was well recognized in antiquity and was often associated with social stigma. In 1873, Dr G. Hansen first identified Mycobacterium leprae as the cause for this condition, which was then named Hansen's disease. Not until the 20th century was specific treatment developed. Leprosy remains endemic to certain areas in the world, especially tropical and subtropical zones. Overall prevalence has decreased, but the reported incidence of leprosy has remained steady, even in the United States. In light of the significant morbidity associated with the disease, physicians must remain vigilant for its signs and symptoms even in developed countries, especially with increasing travel to and from endemic areas.


Carly Ornstein

Latest:

ALA Offers New Resources to IPF Patients

At the most recent American Lung Association LUNGFORCE expo, RDR sat down with Carly Ornstein to discuss the new resources made available by the ALA to individuals affected by lung fibrosis.



Mathew Maurer, M.D.

Latest:

Managing hATTR Amyloidosis

In an interview with Rare Disease Report, Mathew Maurer, MD, Arnold and Arlene Professor of Cardiology at Columbia University, explained the standard of care and current management tactics for individuals with hATTR Amyloidosis.


Louise Pilote, MD, MPH, PhD

Latest:

Angiotensin-converting enzyme inhibitors in elderly patients with acute myocardial infarction: A class effect?

Using a retrospective observational study design, we assessed whether all angiotensin-converting enzyme (ACE) inhibitors had similar mortality rates after acute myocardial infarction in patients aged 65 years or older. Our results showed that mortality rates for enalapril, fosinopril, captopril, and quinapril were higher than that for ramipril. This suggests that there is no class effect for ACE inhibitors. Further research is needed to confirm the results of our study.



Florence N. Hutchison, MD

Latest:

Ethnic differences in blood pressure control in men

We compared blood pressure control among white and African American hypertensive men in Veterans Affairs (VA) and non-VA sites, and found that the dis parity between the two ethnic groups was 40% less at VA sites. Better access to care and medications for African Americans at the VA sites may explain the difference.




Giacomo Levantesi, MD

Latest:

The prognostic role of metabolic syndrome after myocardial infarction

We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.


James R. Couch, MD, PhD

Latest:

Medication Overuse Headache: When the Cure is the Cause of the Pain

Also known as rebound headache, medication overuse headache is a fairly common condition that can be missed by non-specialists who are unfamiliar with its presentation and clinical signs. This article reviews the causes and types of medication overuse headache and discusses the current thinking on treatment.


Roger S. Blumenthal, MD

Latest:

Triglycerides and EPA: A New Chapter in CV Disease Prevention

Findings from REDUCE-IT are the first to show that EPA lowers the relative risk of hard cardiovascular endpoints. Johns Hopkins' Seth Martin, MD, and colleagues put the trial in perspective. 



Amit Phull, MD

Latest:

Healthcare 2020: Video, Vaping, Value and More

From new tech, to better therapy, to resolution on vaping, what will dominate discussion in US medicine this decade?


Keyur B. Shah MD

Latest:

Laboratory monitoring for spironolactone in congestive heart failure

We evaluated how well patients taking spironolactone were monitored for hyperkalemia, as well as the association between spironolactone and hyperkalemia. Only two thirds of patients received testing for serum potassium and creatinine levels, and higher baseline serum creatinine levels predicted a high risk of hyperkalemia. These results indicate that appropriate patient selection and close monitoring are essential, especially for patients with renal impairment.




Enoch Choi, MD

Latest:

After the Tsunami, Physician Volunteers Find Obstacles Both Obvious and Unexpected

Enoch Choi, MD, writes about his experiences leading a disaster relief team in Japan.


Nobuyuki (Bill) Miyawaki, MD, is attending physician, Division of Nephrology

Latest:

Obesity and cardiovascular risk in hypertensive patients with left ventricular hypertrophy

The observed relationship linking obesity, severity of hypertension, and increase in cardiovascular risk was traditionally thought to emanate from the increase in circulatory volume, persistently increased systemic resistance from obesity, and clustering of major cardiovascular risk factors (eg, hypercholesterolemia and diabetes mellitus) among obese patients.


Sam Awada, MD

Latest:

Recognizing the Signs of Pheochromocytoma

Pheochromocytoma is a rare chromaffin cell neoplasm that secretes catecholamines and is usually found in the adrenal medulla. One fourth of these tumors are the result of genetic inheritance. Hypertension is the most common symptom. The classic triad of paroxysmal symptoms?consisting of palpitations, diaphoresis, and headaches?should prompt a consideration of this diagnosis and appropriate laboratory testing. The best biochemical marker is plasma free metanephrines, which is 99% sensitive and 89% specific for diagnosis. Magnetic resonance imaging and radioactive iodine metaiodobenzylguanidine scans are used to localize the tumor before surgery.


Albert Chan, MD, MS, Chief of Digital Patient Experience, Sutter Health

Latest:

Implementing Price Transparency Tools at Ambulatory Care Centers

Patients are satisfied with an online cost-estimator tool, according to findings of a recent study.



Kent Kramer, CFP

Latest:

Physicians' Investment Decisions Magnified Due to Earnings Potential Uncertainty

Many physicians are feeling the earnings squeeze amidst the tectonic shifts in the health care system and changing US demographics.





Amy Watson, MD

Latest:

Swapping Soda for Coffee Can Reduce Stroke Risk

Perhaps, a very simple change in beverage choice could reduce the stroke burden in the United States.

© 2024 MJH Life Sciences

All rights reserved.